One-line Citation Summary

Reference
Duan Shoupeng, Wang Yijun, Yang Xiaomeng, Xu Yanan, Wang Jun. Explainable machine learning-driven predictive modelling of incident cognitive impairment in individuals with early-stage cardiovascular-kidney-metabolic syndrome: Insights from a longitudinal CHARLS cohort study. Diabetes, obesity & metabolism. 2026;28(3):1693-1709. doi:10.1111/dom.70346

Reference
Li J, Miao X, Li Z, Yang J. Advancing brain health prevention using explainable CKM-based predictive modelling. Diabetes, obesity & metabolism. 2026;28(3)(3):2497-2498. doi:10.1111/dom.70437

Reference
Owen A, Ceylan Hİ, Zmijewski P, Biz C, Sciarretta G, Rossin. Socceromics: A Systematic Review of Omics Technologies to Optimize Performance and Health in Soccer.. International journal of molecular sciences. 2026. 27(2)(2). 749.. doi:10.3390/ijms27020749

Reference
Niu G, Cai X, Yang Y, Jing J, Zhang D, Wang. Association of Cardiovascular-Kidney-Syndrome and Brain Macrostructure and Microstructure Injury: A Prospective Cohort Study. Diabetes, obesity & metabolism. 2026;28(5)(5):4148-4161. doi:10.1111/dom.70605

Reference
Lan H, Jia X, Zhao Z, Chen R, Wang B, Qu C, et al. TyG and RC combined with CVD risk in CKM syndrome: A national cohort study. iScience. 2026;29(3):115060. doi:10.1016/j.isci.2026.115060

Reference
Yang Y, Zhou W, Yang M, Tang SCW, Liu BC. Current understanding of sodium-glucose transporter 2 inhibitors in cardiovascular-kidney-metabolic syndrome. Frontiers in Pharmacology. 2026;17:1800868. doi:10.3389/fphar.2026.1800868

Reference
Zheng Z, Yin X, Liu J, Zhang Y. Triglyceride-glucose index and its derivatives as emerging biomarkers of insulin resistance for prognostic evaluation of cardiovascular-kidney-metabolic syndrome: mechanisms and clinical applications. Frontiers in Pharmacology. 2026;17:1787130. doi:10.3389/fphar.2026.1787130

Reference
Palazzuoli A, Mattioli AV, Fedele F. Current Appraisal and Gaps in Knowledge in Cardio-Kidney Metabolic Syndrome Definition. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026;27(4):1657. doi:10.3390/ijms27041657

Reference
Hsu CN, Tain YL. Melatonin as a Redox Modulator in Developmental Programming: Implications for Cardiovascular-Kidney-Metabolic Risk. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026;27(5):2390. doi:10.3390/ijms27052390

Reference
Kuo YJ, Chen LF, Chen Y, Chen PL, Lin HY. Mitochondrial Dysfunction at the Intersection of CKM Syndrome: Molecular Mechanisms and Path-to-Target Therapies. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026;27(9):4120. doi:10.3390/ijms27094120

Reference
Chen H, Wu JY, Yan H, Gao J, Li C, Xie JH. Association of Remnant Cholesterol Inflammatory Index with Stroke, Heart Disease and All-Cause Mortality Across Cardiovascular-Kidney-Metabolic Syndrome Stages 0-3: A National Cohort Study. Nutrients. 2026;18(2):205. doi:10.3390/nu18020205

Reference
Soliman GA. Cardiovascular-Kidney-Metabolic (CKM) Syndrome Staging and Relevance to Precision Nutrition. Nutrients. 2026;18(9):1430. doi:10.3390/nu18091430

Reference
Singar S, Kachouei AA, Lantigua-Somoano L, Manley D, Cardinale A. Ultra-Processed Foods and the Cardiovascular-Kidney-Metabolic Continuum: Integrating Epidemiological, Multi-Omics, and Translational Evidence. Nutrients. 2026;18(7):1039. doi:10.3390/nu18071039

Reference
Fu P, Zheng H, Wu K, Lan Y, Wu D, Wu W, et al. 2026. Adherence to the EAT-Lancet diet and the risk of heart failure in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: A prospective cohort study. Frontiers in Nutrition. 2026;13:1802388. doi:10.3389/fnut.2026.1802388

Reference
Tang Y, Xu W, Jiang Y, Liu C, Zhu W, Liu D, et al. 2026. Associations between lipid-derived indices and cardiovascular-kidney-metabolic syndrome progression among Chinese middle-aged and elderly adults: a longitudinal study. Frontiers in Nutrition. 2026;13:1742974. doi:10.3389/fnut.2026.1742974

Reference
Tu J, Chen F, Yan W, Xu Z, Zhan Y, Yang X. 2026. Development and validation of a prediction model for cardiovascular-kidney-metabolic syndrome progression: a multicenter study. Frontiers in Nutrition. 2026;13:1783262. doi:10.3389/fnut.2026.1783262

Reference
Yang J, Deng Z, Xie B, Tian F, Leng Y, Zhou H. 2026. The Triglyceride-Glucose-Chinese Visceral Adiposity Index (TyG-CVAI) outperforms other insulin resistance indices in its association with cardiovascular-kidney-metabolic syndrome severity in type 2 diabetes: a comparative study. Frontiers in Nutrition. 2026;13:1817071. doi:10.3389/fnut.2026.1817071

Reference
Zhang LL, Zhu XG, Chen J, Nie P, Shi JC, Zhang Z, et al. Association of Higher Dietary Omega-3 Fatty Acid Intake With Cardiovascular-Kidney-Metabolic Syndrome Stage Severity and Mortality in US Adults: A Cross-Sectional and Prospective Cohort Analysis of NHANES 1999 to 2018. Journal of the American Heart Association. 2026;15(2):e046079. doi:10.1161/JAHA.125.046079

Reference
Liu H, Wu S, Huang B, Liu Y, Zhong Z, Zhao. Effect of Mitochondria-Derived Methylmalonic Acid on Progress and Mortality Risk in US Adults With Cardiovascular-Kidney-Metabolic Syndrome. Journal of the American Heart Association. 2026;15(2):e043066. doi:10.1161/JAHA.125.043066

Reference
Marchetti M, Antiochos P, Pitta-Gros B, Abdurashidova T. Prognostic Impact of Cardiovascular-Kidney-Metabolic Overlap Among Patients With Acute Heart Failure: Insights From a Real-World Multinational Cohort. Journal of the American Heart Association. 2026;15(1):e045294. doi:10.1161/JAHA.125.045294

Reference
Caramori ML, Repetto E, Perkins C, Pandey A, Rossing P. Cardio-Kidney-Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease. DIABETES OBESITY and METABOLISM. 2026;28(5):4344-4351. doi:10.1111/dom.70640

Reference
Yang Y, Liu Y, Han S, Liu Z, Yu J, Xing B. Comparative Associations of Traditional and New Obesity Framework With Cardio-Kidney-Metabolic Syndrome and All-Cause Mortality: A Prospective Cohort Study. DIABETES OBESITY and METABOLISM. 2026. doi:10.1111/dom.70883

Reference
Ferreira JP, Marques P, Anker SD, Butler J, Filippatos G. Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular-kidney-metabolic conditions: A pooled analysis of randomised trials. DIABETES OBESITY and METABOLISM. 2026;28(2):1105-1115. doi:10.1111/dom.70289

Reference
Zeitler E, Klein KR, Lingvay I, Pick A, Billings LK. Online ahead of print. Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic Syndrome. DIABETES OBESITY and METABOLISM. 2026. doi:10.1111/dom.70781

Reference
Han X, Ding J, Li J, Gao Y, Li Y. Proteomic Profiling Captures Residual Cardiovascular Risk Beyond the PREVENT Model in Individuals With Cardiovascular-Kidney-Metabolic Syndrome Stages 2-3. DIABETES OBESITY and METABOLISM. 2026. doi:10.1111/dom.70933

Reference
Li Z, Chen M. Serum glycated albumin-to-albumin ratio and mortality risk in cardiovascular-kidney-metabolic syndrome: Evidence from NHANES over 15 years. DIABETES OBESITY and METABOLISM. 2026;28(3):2038-2050. doi:10.1111/dom.70387

Reference
Li J, Chen S, Zhang X, Xia X, Yan Y. The Evolving Role of High-Sensitivity C-Reactive Protein for Mortality Prediction Across the Spectrum of Cardiovascular-Kidney-Metabolic Syndrome. DIABETES OBESITY and METABOLISM. 2026. doi:10.1111/dom.70843

Reference
Wen W, Liu Z, Li L, Qiu F, Zhang H, Cao Y, et al. Multimodal mechanisms of di (2-ethylhexyl) phthalate-induced cardiovascular-kidney-metabolic syndrome: Integrating epidemiology, network toxicology and experimental validation. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY. 2026;309:119515. doi:10.1016/j.ecoenv.2025.119515

Reference
Amujilite, Yin G, Chen Z, Wu J, Dong Z, Zhang S, et al. Urinary metal mixtures and cardio-kidney-metabolic risk in adults from a legacy-contaminated area: Repeated-measures cohort evidence and computational validation. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY. 2026;314:120039. doi:10.1016/j.ecoenv.2026.120039

Reference
Lawton E, Perz L, Pasqua MR, Tsoukas M, Haidar. Online ahead of print. Continuous Ketone Monitoring Captures Overt Ketosis in Type 1 Diabetes Caused by Empagliflozin, Low-Carbohydrate Diet, and Exercise. Diabetes Technology and Therapeutics. 2026. doi:10.1177/15209156261420167

Reference
Ngan J, Kong YW, Jones HC, Goad J, Kriketos A,. 10.1177/15209156261420186. Online ahead of print. Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.. Diabetes Technology and Therapeutics. 2026. doi:10.1177/15209156261420186

Reference
Haas NL, Korley FK, Schneider RM, Mamillapalli SL, Hepworth E. Online ahead of print. Continuous Ketone Monitoring in Diabetic Ketoacidosis: Prospective Multicenter Method-Comparison and Feasibility Study. Diabetes Technology and Therapeutics. 2026. doi:10.1177/15209156261428034

Reference
Kong YW, Jones HC, Ngan J, Goad J, Jenkins. Preventing Diabetic Ketoacidosis with Continuous Ketone Monitoring: Insights from a Clinical Research Case.. Diabetes Technology and Therapeutics. 2026. 28(1). 73-77.. doi:10.1177/15209156251362494

Reference
Liu S, Man Q, Wang S, Huang Y, Wen J, Yang Y, et al. Kidney function decline mediates the adverse effects of arterial stiffness on all-cause and cardiovascular disease mortality in Cardiovascular-Kidney-Metabolic syndrome population: A cohort study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2026;231:113051. doi:10.1016/j.diabres.2025.113051

Reference
Yin S, Yan S, Yang Z, Zhu P, Tang T, Borné Y. Association between Life's Simple 7 and life's essential 8 with all-cause and cardiovascular mortality in cardiovascular-kidney-metabolic syndrome population. DIABETES RESEARCH AND CLINICAL PRACTICE. 2026;231:113064. doi:10.1016/j.diabres.2025.113064

Reference
Xie N, Zeng L, Hu X, Wu Z, Lu W, Luo S, et al. Association of remnant cholesterol inflammation index with future cardiovascular disease risk in patients with cardiovascular-kidney-metabolic syndrome stages 0-3. DIABETES RESEARCH AND CLINICAL PRACTICE. 2026;233:113146. doi:10.1016/j.diabres.2026.113146

Reference
Masrouri S, Ebrahimi N, Hasanpour A, Sohrabi B, Azizi F, Hadaegh. Cardiovascular-kidney-metabolic syndrome stages, stage transitions, and risk of cardiovascular disease and mortality: The Tehran Lipid and Glucose Study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2026;235:113223. doi:10.1016/j.diabres.2026.113223

Reference
Hao WR, Liu JC, Fang YA, Hsu MH, Hsiu H, Chen CC. Cardiorenal protective effects of anti-diabetic drugs in early stage Cardiovascular-Kidney-Metabolic Syndrome: A multicenter, time-varying analysis. DIABETES RESEARCH AND CLINICAL PRACTICE. 2026;236:113233. doi:10.1016/j.diabres.2026.113233

Reference
Xiang S, Nie H, Wei Z, Li Y, Wang C, Che X, et al. Cardiovascular-kidney-metabolic syndrome stages and risk of diverse gastrointestinal diseases: a prospective cohort study and integrative proteomic analysis. DIABETES RESEARCH AND CLINICAL PRACTICE. 2026;236:113266. doi:10.1016/j.diabres.2026.113266

Reference
Wu JY, Lee KW, Huang SC, Chang HY, Lin YM. 10.1016/j.diabres.2026.113273. Epub 2026 Apr 19. Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on cardiovascular-kidney-metabolic stage progression: a real-world cohort study.. DIABETES RESEARCH AND CLINICAL PRACTICE. 2026. 236. 113273.. doi:10.1016/j.diabres.2026.113273

Reference
Avogaro A, Fiaccadori E, Rizzo MR. 10.1016/j.diabres.2026.113288. Online ahead of print. DPP-4 inhibitors in current diabetes care: their foundational role in treating to target.. DIABETES RESEARCH AND CLINICAL PRACTICE. 2026. 237. 113288.. doi:10.1016/j.diabres.2026.113288

Reference
He L, Lin H, Zhang X, Ling X. Online ahead of print. Risk stratification in early-stage Cardiovascular-Kidney-Metabolic Syndrome: The Potency of visceral adiposity and insulin resistance surrogate indices. DIABETES RESEARCH AND CLINICAL PRACTICE. 2026;237:113336. doi:10.1016/j.diabres.2026.113336

Reference
Agboola OJ, Chan JSK, Spitz JA, Chan RNC, Patel J. The role of inflammation in longitudinal renal function decline and incident chronic kidney disease: the multi-ethnic study of atherosclerosis. European Journal of Preventive Cardiology. 2026;33(5):718-728. doi:10.1093/eurjpc/zwaf779

Reference
Fang Y, Huang S, Zhang H, Li M, Zhang H, Yang W, et al. ahead of print. Frailty as a Risk-Enhancing Factor Across the Cardiovascular-Kidney-Metabolic Framework: Findings from the UK Biobank. European Journal of Preventive Cardiology. 2026. doi:10.1093/eurjpc/zwag170

Reference
Gao Q, Ren W, Du X, Yu Y, Ma Z, Cui Y, et al. ahead of print. Sex-Specific Associations Between Depression and Cardiovascular-Kidney-Metabolic Syndrome Progression: A National Cohort Study. European Journal of Preventive Cardiology. 2026. doi:10.1093/eurjpc/zwag135

Reference
Hartsell SE, Wei G, Singh R, Throolin M. Online ahead of print. Comparative Effectiveness of SGLT2 Inhibitor and GLP-1 Receptor Agonist on Kidney and Cardiovascular Outcomes by Kidney Failure Risk. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2026. doi:10.1681/ASN.0000001016

Reference
Mathew GG. Finerenone in CKD: Enhancing the Evidence Base in Real-World Contexts. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2026;37(2):423-424. doi:10.1681/ASN.0000000956

Reference
Wang A, Li Y. Finerenone in CKD from Estimands to Clinical Interpretability under Competing Risk. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2026;37(2):425-426. doi:10.1681/ASN.0000000925

Reference
Levin A, Bansal N, de Boer IH, Grams ME, Jadoul M, Ter Maaten. Online ahead of print. The Kidney in the Middle: KDIGO Guidelines Address Multiple Key Components of Cardiovascular-Kidney-Metabolic Syndrome. KIDNEY INTERNATIONAL. 2026. doi:10.1016/j.kint.2026.03.031

Reference
Ren X, Gao D, Yun R, Liu X, Di C, Hu Z, et al. A urea-activated nanocarrier for site-specific SGLT2 inhibition and metabolic rescue against cardiovascular-kidney-metabolic syndrome. Nature Communications. 2026. doi:10.1038/s41467-026-71424-w

Reference
Lassen MCH, Ostrominski JW, Claggett BL, Ndumele CE. Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study. Circulation. 2026;153(17):1268-1280. doi:10.1161/CIRCULATIONAHA.125.077894

Reference
Drexler Y, Fornoni A. Advances in risk prediction and treatment strategies for CKM syndrome. Nature Reviews Nephrology. 2026;22(2):95-96. doi:10.1038/s41581-025-01044-y

Reference
Alicic RZ, Neumiller JJ, Tuttle KR. GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease. Nature Reviews Nephrology. 2026;22(4):265-282. doi:10.1038/s41581-025-01036-y

Reference
Mavromatis LA, Grams ME. print. Epidemiology of cardiovascular-kidney-metabolic syndrome. Nature Reviews Nephrology. 2026. doi:10.1038/s41581-026-01078-w

Reference
Xie Peichen, Wang Yiqin, Xu Xinghao, Tan Li, Guo Xingdi, Xu Ziqi, et al. Association of Cardiovascular-Kidney-Metabolic Syndrome With Cognitive Decline and Dementia: The ARIC Study Insights. Journal of the American Heart Association. 2025;14(10):e038445. doi:10.1161/JAHA.124.038445

Reference
Zhu R, Wang R, He J, Wang L, Chen H, Wang Y, et al. Associations of cardiovascular-kidney-metabolic syndrome stages with premature mortality and the role of social determinants of health. Journal of Nutrition Health and Aging. 2025;29(4):100504. doi:10.1016/j.jnha.2025.100504

Reference
Li J, Lei L, Zhang L, Guo Y, Yuan X. Cardiovascular-kidney-metabolic overlaps, clinical outcomes, and quality of life in patients with acute heart failure. Journal of Nutrition Health and Aging. 2025;29(8):100613. doi:10.1016/j.jnha.2025.100613

Reference
Tang H, Zhang X, Luo N, Huang J, Yang Q, Lin H, et al. Temporal trends in the planetary health diet index and its association with cardiovascular, kidney, and metabolic diseases: A comprehensive analysis from global and individual perspectives. Journal of Nutrition Health and Aging. 2025;29(5):100520. doi:10.1016/j.jnha.2025.100520

Reference
Yang Z, Zhou P, Fan F, Hao Y, Zhao W, Wang Z, et al. A simple score, CKM(2)S(2)-BAG, to predict cardiovascular risk with cardiovascular-kidney-metabolic health metrics. iScience. 2025;28(7):112780. doi:10.1016/j.isci.2025.112780

Reference
Bandara D, Smit J, Wohnlich S, Heinze T. Exploring a long distance, amagmatic, across-suture orogenic geothermal system: Sri Lanka's foreland hot springs.. iScience. 2025. 28(5). 112370.. doi:10.1016/j.isci.2025.112370

Reference
Bi X, Shen Y, Shen Y, Shen A, Zhou S, Wang W, et al. 2025 Apr. Prognosis of non-albuminuric patients with the cardiovascular-kidney-metabolic syndrome. Clinical Kidney Journal. 2025;18(4):sfaf074. doi:10.1093/ckj/sfaf074

Reference
Sowden R, Shaw C, Robb J, Winterbottom A, Bristowe K, Bekker. 2025 Jun. How do patient information documents present dialysis and conservative kidney management? A document analysis.. Clinical Kidney Journal. 2025. 18(6). sfaf136.. doi:10.1093/ckj/sfaf136

Reference
Wen S, Fu A, Liu F, You Y,. eCollection 2025. Identifying potential drugs for treating Cardiovascular-kidney metabolic syndrome via reverse network pharmacology.. Frontiers in Pharmacology. 2025. 16. 1627236.. doi:10.3389/fphar.2025.1627236

Reference
Gerdanovics CA, Suciu ȘM, Orășan OH, Para I, Turi VR, Milaciu. Adipokines and Vascular Modulators in CKM: Emerging Biomarkers as Diagnostic and Therapeutic Targets.. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025. 26(22). 11083.. doi:10.3390/ijms262211083

Reference
Peng Y, Yan L, Zhao C, Zhang B, Zhang B, Qiu. Effects of Temperature and Salinity on Ovarian Development and Differences in Energy Metabolism Between Reproduction and Growth During Ovarian Development in the Lateolabrax maculatus. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025;26(17):8295. doi:10.3390/ijms26178295

Reference
John L, Munk M, Bizjak R, Schulz SVW, Witzel J, Engler H,. Does Distance Matter? Metabolic and Muscular Challenges of a Non-Stop Ultramarathon with Sub-Analysis Depending on Running Distance.. Nutrients. 2025. 17(23). 3801.. doi:10.3390/nu17233801

Reference
Varillas-Delgado D. Influence of Genetic Polymorphisms and Biochemical Biomarkers on Response to Nutritional Iron Supplementation and Performance in a Professional Football Team: A Pilot Longitudinal Study. Nutrients. 2025;17(8):1379. doi:10.3390/nu17081379

Reference
Palumbo P, Alfano G, Cavani F, Giannini R, Pulizzi RA, Gabriele. Medical Nutrition Therapy Adherence and Lifestyle in Stage 5 CKD: Challenges and Insights.. Nutrients. 2025. 17(19). 3091.. doi:10.3390/nu17193091

Reference
Yin X, Zou J, Yang J. 2025. Altered albumin/neutrophil to lymphocyte ratio are associated with all-cause and cardiovascular mortality for advanced cardiovascular-kidney-metabolic syndrome.. Frontiers in Nutrition. 2025. 12. 1595119.. doi:10.3389/fnut.2025.1595119

Reference
Wang G, Li G, Wang P, Zang M, Pu J. 2025. Association between albumin to globulin ratio and all-cause and cardiovascular mortality among individuals with cardiovascular-kidney-metabolic syndrome: results from NHANES 2003 to 2018.. Frontiers in Nutrition. 2025. 12. 1622590.. doi:10.3389/fnut.2025.1622590

Reference
Chen Y, Tu H, Liang M, Shen M. 2025. Association between body roundness index and advanced cardiovascular-kidney-metabolic syndrome. Frontiers in Nutrition. 2025;12:1623766. doi:10.3389/fnut.2025.1623766

Reference
Long D, Mao C, An H, Zhu Y, Xu Y. 2025. Association between dietary index for gut microbiota and cardiovascular-kidney-metabolic syndrome: a population-based study. Frontiers in Nutrition. 2025;12:1594481. doi:10.3389/fnut.2025.1594481

Reference
Yu H, Liu Y, Zhang T, Guan Z, Li P. 2025. Association between dietary inflammatory index score and cardiovascular-kidney-metabolic syndrome: a cross-sectional study based on NHANES. Frontiers in Nutrition. 2025;12:1557491. doi:10.3389/fnut.2025.1557491

Reference
Duan Y, Yang K, Zhang T, Guo X, Yin Q, Liu H. 2025. Association between non-highdensity lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiovascular-kidney-metabolic syndrome: evidence from NHANES 2001-2018. Frontiers in Nutrition. 2025;12:1548851. doi:10.3389/fnut.2025.1548851

Reference
Shi L, Zhang D, Zhang S. 2025. Association between oxidative balance score with cardiovascular - kidney - metabolic syndrome and all-cause mortality among US population. Frontiers in Nutrition. 2025;12:1564368. doi:10.3389/fnut.2025.1564368

Reference
He Q, Hu F, Wei W, Li J, Yu Y, Zhang H. 2025. Association between the composite dietary antioxidant index and cardiovascular-kidney-metabolic syndrome among U.S. adults: evidence from NHANES 2007-2018. Frontiers in Nutrition. 2025;12:1600651. doi:10.3389/fnut.2025.1600651

Reference
Tian RN, Zhang SX, Zhang N, Wu WJ, Guo HQ, Wang C. 2025. Association between the dietary inflammatory index and depressive symptoms in adults with cardiovascular-kidney-metabolic syndrome: evidence of metabolic syndrome as a mediator. Frontiers in Nutrition. 2025;12:1623482. doi:10.3389/fnut.2025.1623482

Reference
Tu D, Zuo X, Li P, Wang J. 2025. Association between the life's essential 8 health behaviors score and all-cause mortality in cardiovascular-kidney-metabolic syndrome patients.. Frontiers in Nutrition. 2025. 12. 1612693.. doi:10.3389/fnut.2025.1612693

Reference
Liu J, Song Y, Luo R, Wang S, Pan P, Han L. 2025. Association between urinary heavy metals and cardiovascular-kidney-metabolic syndrome: mediating roles of TyG, WWI, and eGFR. Frontiers in Nutrition. 2025;12:1613721. doi:10.3389/fnut.2025.1613721

Reference
Pengfei C, Lui M, Zhang L, Chen C, Wang T, Ailin H. 2025. Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study. Frontiers in Nutrition. 2025;12:1661826. doi:10.3389/fnut.2025.1661826

Reference
Liu W, Li Z, Ma P. 2025. Association of cardiovascular-kidney-metabolic syndrome with depression and all-cause mortality: a population-based observational study.. Frontiers in Nutrition. 2025. 12. 1620008.. doi:10.3389/fnut.2025.1620008

Reference
Hu S, Wei B, Zhang A. 2025. Association of multiple dietary metal intake with cardiovascular-kidney-metabolic syndrome: a cross-sectional study based on NHANES 2003-2018.. Frontiers in Nutrition. 2025. 12. 1612458.. doi:10.3389/fnut.2025.1612458

Reference
Xu Y. 2025. Association of neutrophil/high-density lipoprotein cholesterol ratio with the cardiovascular-kidney-metabolic syndrome and its cardiovascular mortality. Frontiers in Nutrition. 2025;12:1594041. doi:10.3389/fnut.2025.1594041

Reference
Li J, Xu Z, Lin J, Luo S, Xu S. 2025. Associations between Life's Crucial 9 and severity, all-cause mortality, and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: the mediating role of phenotypic age acceleration.. Frontiers in Nutrition. 2025. 12. 1612293.. doi:10.3389/fnut.2025.1612293

Reference
Liang J, Liang Y, Chen L, Cai M, Li S, He L. 2025. Cardiovascular-kidney-metabolic progression associated with major adverse liver outcomes: mediating roles of plasma metabolites. Frontiers in Nutrition. 2025;12:1675899. doi:10.3389/fnut.2025.1675899

Reference
Huang J, Liu Z, Feng W, Huang Y, Cheng X. 2025. Machine learning with decision curve analysis evaluates nutritional metabolic biomarkers for cardiovascular-kidney-metabolic risk: an NHANES analysis. Frontiers in Nutrition. 2025;12:1597864. doi:10.3389/fnut.2025.1597864

Reference
Wang Z, Fang L, Wang L, Zhang J. 2025. Non-linear associations and threshold effects of oxidative balance score and composite dietary antioxidant index on frailty risk in patients with cardiovascular-kidney-metabolic syndrome. Frontiers in Nutrition. 2025;12:1673736. doi:10.3389/fnut.2025.1673736

Reference
Xie D, You F, Yang L, Li C, Liu F. 2025. The role of oxidative balance score in Cardiovascular-Kidney-Metabolic syndrome progression and mortality: insights from NHANES 1999-2020. Frontiers in Nutrition. 2025;12:1597693. doi:10.3389/fnut.2025.1597693

Reference
Shi P, Lou C, Fang J, Song Y. Adverse Life Events Across the Life Course and the Risk of New-Onset Cardiovascular-Kidney-Metabolic Multimorbidity in Middle-Aged and Older Adults: Longitudinal Evidence From CHARLS. Journal of the American Heart Association. 2025;14(24):e045192. doi:10.1161/JAHA.125.045192

Reference
Liu Z, Zhou D, Tang Y, Huo G. Association of Atherogenic Index of Plasma With Stroke Risk in a Population With Cardiovascular-Kidney-Metabolic Syndrome Stages 0 to 3: The First Evidence From the China Health and Retirement Longitudinal Study. Journal of the American Heart Association. 2025;14(14):e039983. doi:10.1161/JAHA.124.039983

Reference
Vieira de Oliveira Salerno PR, Lewis PGT, Chen Z, Dazard JE, Ganatra. Climate Vulnerability and Cardiovascular-Kidney-Metabolic Disease in the United States.. Journal of the American Heart Association. 2025. 14(11). e038251.. doi:10.1161/JAHA.124.038251

Reference
Wu S, Zhu J, Lyu S, Wang J, Shao X, Zhang H,. Impact of DNA-Methylation Age Acceleration on Long-Term Mortality Among US Adults With Cardiovascular-Kidney-Metabolic Syndrome.. Journal of the American Heart Association. 2025. 14(7). e039751.. doi:10.1161/JAHA.124.039751

Reference
Kawaharata W, Tanaka M, Sato T, Akiyama Y, Hosaka I, Aida. Incorporation of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Health Stage of Cardiovascular-Kidney-Metabolic Syndrome Improves Predictive Ability for Coronary Artery Disease in a Japanese General Population.. Journal of the American Heart Association. 2025. 14(16). e043173.. doi:10.1161/JAHA.125.043173

Reference
Tu D, Sun J, Wang P, Xu Q, Ma C. Overall Sleep Quality Is Associated With Advanced Stages in Patients With Cardiovascular-Kidney-Metabolic Syndrome. Journal of the American Heart Association. 2025;14(7):e038674. doi:10.1161/JAHA.124.038674

Reference
Baker-Smith CM, Gauen AM, Petito LC, Khan SS, Allen. Prevalence of Cardiovascular-Kidney-Metabolic Stages in US Adolescents and Relationship to Social Determinants of Health. Journal of the American Heart Association. 2025;14(10):e040269. doi:10.1161/JAHA.124.040269

Reference
Wang L, Zhang X, Chen Y, Flynn CR, English WJ, Samuels JM. Reduced Risk of Cardiovascular Diseases After Bariatric Surgery Based on the New Predicting Risk of Cardiovascular Disease EVENTs Equations. Journal of the American Heart Association. 2025;14(6):e038191. doi:10.1161/JAHA.124.038191

Reference
Ao N, Du J, Jin S, Suo L, Yang J. The cellular and molecular mechanisms mediating the protective effects of sodium-glucose linked transporter 2 inhibitors against metabolic dysfunction-associated fatty liver disease. DIABETES OBESITY and METABOLISM. 2025;27(2):457-467. doi:10.1111/dom.16043

Reference
Koubar SH, Hatab T, Razzak FA, Helal I, Ali A, Shebani A,. eCollection 2025 Apr. Conservative Kidney Management in the Middle East and North Africa: Attitudes, Practices, and Implementation Barriers.. Kidney International Reports. 2025. 10(4). 1076-1086.. doi:10.1016/j.ekir.2025.01.011

Reference
Li PK, Cheung M, Chow KM, Leung MKW, Lim LL, Lui. eCollection 2025 Aug. Kidney Disease: Improving Global Outcomes Summit Recommendations on Implementation of Diabetes Management in CKD: From Primary to Data-Driven Collaborative Care.. Kidney International Reports. 2025. 10(8). 2551-2565.. doi:10.1016/j.ekir.2025.06.010

Reference
He Y, Zhou X, Huang W, Wu Y, Zhang Z, Jin Y, et al. 10.1016/j.ecoenv.2025.118885. Epub 2025 Aug 16. Cadmium exposure and advanced cardiovascular-kidney-metabolic syndrome: An integrated multi-organ perspective based on epidemiology and adverse outcome pathways.. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY. 2025. 303. 118885.. doi:10.1016/j.ecoenv.2025.118885

Reference
Fan S, Hu H, Li Y, Deng Y, Wang S, Xian J, et al. Effects of ambient air pollution mixtures and household fuel use on progression to advanced cardiovascular-kidney-metabolic syndrome among middle-aged and older adults. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY. 2025;303:118915. doi:10.1016/j.ecoenv.2025.118915

Reference
Ma J, Li P, Tao L, Yang X, Luo Y, Guo X, et al. Environment-wide association study of cardiovascular-kidney-metabolic syndrome based on NHANES 2013-2016. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY. 2025;303:118993. doi:10.1016/j.ecoenv.2025.118993

Reference
Zhang X, Zhu X, Gu W, Li X, Niu T, Mao P, et al. Elucidating the mechanism of phthalates induced osteoporosis through network toxicology and molecular docking. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY. 2025;291:117820. doi:10.1016/j.ecoenv.2025.117820

Reference
Wang M, Lin W, Liu H, Qian ZM, Chen J, Rao M, et al. Associations between insulin resistance indices and cardiovascular disease in older adults with cardiovascular-kidney-metabolic syndrome stage 0-3: The GOLD-Health cohort. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025;226:112327. doi:10.1016/j.diabres.2025.112327

Reference
Qi X, Sui J, Yang Z, Dahlen A, Zhang K, Wu B. 10.1016/j.diabres.2025.112437. Epub 2025 Aug 25. Periodontitis, accelerated biological aging, and advanced stages in cardiovascular-kidney-metabolic syndrome in U.S. Adults: A mediation analysis.. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025. 228. 112437.. doi:10.1016/j.diabres.2025.112437

Reference
Ren H, Hu M, Yan Y, Cheng M, Yang C, Yuan G, et al. Association of the metabolic dysfunction-associated steatotic liver disease with cardiovascular and kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025;229:112927. doi:10.1016/j.diabres.2025.112927

Reference
Li Y, Luo Z, Zhang Z, Huang N, Xiao L, Li J, et al. Exploring the mediating role of TyG-related indicators in the relationship between biological aging and late-stage cardiovascular-kidney-metabolic in middle-aged and older adults. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025;230:112988. doi:10.1016/j.diabres.2025.112988

Reference
Zhang C, Chen Y, Wang T, Peng W, Ning M, Liu Y. Inflammation and abnormal glucose-lipid metabolism are critical for population stratification toward progressive frailty in Cardiovascular-Kidney-Metabolic syndrome. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025;230:112989. doi:10.1016/j.diabres.2025.112989

Reference
Ding X, Tian J, Chang X, Liu J, Wang G. Association between remnant cholesterol and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China health and retirement longitudinal study. European Journal of Preventive Cardiology. 2025;32(13):1157-1165. doi:10.1093/eurjpc/zwaf248

Reference
Yang C, Li Z, Sui Y, Long T, Cheng S, Guo X, et al. Sex differences in cardiovascular-kidney-metabolic risk factors associated with degenerative valvular heart disease.. European Journal of Preventive Cardiology. 2025. 32(17). 1705-1715.. doi:10.1093/eurjpc/zwaf050

Reference
Tan S, Zhou J, Li F, Zeng G, Liu. ahead of print. Association between the Life's Essential 8 Health Behaviors and Prognosis in Patients with Advanced Cardiovascular-Kidney-Metabolic Syndrome.. European Journal of Preventive Cardiology. 2025. doi:10.1093/eurjpc/zwaf443

Reference
Nakade T, Matsue Y, Ikeda Y, Maeda D, Kagiyama N, Fujimoto. ahead of print. Association of Cardiovascular-Kidney-Metabolic Overlap with Physical Function and Prognosis in Older Patients with Heart Failure: A Post-hoc Analysis of the FRAGILE-HF and SONIC-HF.. European Journal of Preventive Cardiology. 2025. doi:10.1093/eurjpc/zwaf279

Reference
Yang M, Su C, Chang X, Wang G, Liu J. ahead of print. Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome. European Journal of Preventive Cardiology. 2025. doi:10.1093/eurjpc/zwaf708

Reference
Kim BS, Kim HJ, Kim H, Lee J, Ahn SB, Shin JH, et al. ahead of print. Hepatic Steatosis in Cardiovascular-Kidney-Metabolic Syndrome: Fatty Liver Index as a Predictor of Cardiovascular Outcomes.. European Journal of Preventive Cardiology. 2025. doi:10.1093/eurjpc/zwaf396

Reference
Ha KH, Kim DJ, Lee H. ahead of print. MASLD in the CKM health framework: what does it add to the table?. European Journal of Preventive Cardiology. 2025. doi:10.1093/eurjpc/zwaf549

Reference
Tran DT, Strohmaier S, Żebrowska M, Huang T, Papantoniou K,. ahead of print. Night shift work and its interaction with sleep duration and chronotype, and risk of cardiovascular-kidney-metabolic diseases in the UK Biobank.. European Journal of Preventive Cardiology. 2025. doi:10.1093/eurjpc/zwaf774

Reference
Abudoureheman W, Zhang F, Sun Q. ahead of print. Remnant Cholesterol in CHARLS: Unaddressed Dynamic Changes and Clinical Confounders in CKM Progression Analysis. European Journal of Preventive Cardiology. 2025. doi:10.1093/eurjpc/zwaf391

Reference
Rumrill SM, Shlipak MG. The New Cardiovascular-Kidney-Metabolic (CKM) Syndrome: An Opportunity for CKD Detection and Treatment in Primary Care.. AMERICAN JOURNAL OF KIDNEY DISEASES. 2025. 85(4). 399-402.. doi:10.1053/j.ajkd.2024.09.016

Reference
Claudel SE, Schmidt IM, Waikar SS, Verma A. Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic (CKM) Syndrome. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2025;36(7):1343-1351. doi:10.1681/ASN.0000000637

Reference
Xie Z, Yu C, Cui Q, Zhao X, Zhuang J, Chen S, et al. Global Burden of the Key Components of Cardiovascular-Kidney-Metabolic Syndrome. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2025;36(8):1572-1584. doi:10.1681/ASN.0000000658

Reference
Ortiz A, Arreola Guerra JM, Chan JCN, Jha V, Kramer H, Nicholas. Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. KIDNEY INTERNATIONAL. 2025;108(4):555-571. doi:10.1016/j.kint.2025.04.005

Reference
Bollinger E, Williams G, Piper ME, Steen K, Neale KT, Chen X. Restoration of branched chain amino acid catabolism improves kidney function in preclinical cardiovascular-kidney-metabolic syndrome models. KIDNEY INTERNATIONAL. 2025;108(2):310-316. doi:10.1016/j.kint.2025.04.025

Reference
Xu X, Shao X, Hou FF. Risk stratification of metabolic disorder-associated kidney disease.. KIDNEY INTERNATIONAL. 2025. 107(6). 1002-1010.. doi:10.1016/j.kint.2025.01.041

Reference
Semprich J, Filiberto J, Weller M, Gorce J, Clark N. Metamorphism of Venus as driver of crustal thickness and recycling.. Nature Communications. 2025. 16(1). 2905.. doi:10.1038/s41467-025-58324-1

Reference
Collaborators: Ablikim M, Achasov MN, Adlarson P, Afedulidis O, Ai XC, Aliberti. Observation of a rare beta decay of the charmed baryon with a Graph Neural Network. BESIII Collaboration.. Nature Communications. 2025. 16(1). 681.. doi:10.1038/s41467-024-55042-y

Reference
Moreno-Pérez O, Reyes-García R, Modrego-Pardo I, López-Martínez. 2024 Apr. Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?. Clinical Kidney Journal. 2024;17(4):sfae039. doi:10.1093/ckj/sfae039

Reference
Abasheva D, Ortiz A, Fernandez-Fernandez B. GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity. Clinical Kidney Journal. 2024;17(Suppl. doi:10.1093/ckj/sfae296

Reference
Luo J, Guo M, Xie K, Han TL, Ai S. Metabolomic analysis of Agkistrodon haly venom poisoning mouse treatment by Jidesheng snake pill based on GC-MS. Frontiers in Pharmacology. 2024;15:1419609. doi:10.3389/fphar.2024.1419609

Reference
Tain YL, Hsu CN. Maternal Dietary Strategies for Improving Offspring Cardiovascular-Kidney-Metabolic Health: A Scoping Review.. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024. 25(18). 9788.. doi:10.3390/ijms25189788

Reference
Lizcano-Álvarez Á, Varillas-Delgado D, Cano-de-la-Cuerda R. The Association of Genetic Markers Involved in Muscle Performance Responding to Lactate Levels during Physical Exercise Therapy by Nordic Walking in Patients with Long COVID Syndrome: A Nonrandomized Controlled Pilot Study. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024;25(15):8305. doi:10.3390/ijms25158305

Reference
Tain YL, Hsu CN. The Impact of the Aryl Hydrocarbon Receptor on Antenatal Chemical Exposure-Induced Cardiovascular-Kidney-Metabolic Programming.. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024. 25(9). 4599.. doi:10.3390/ijms25094599

Reference
Tain YL, Hsu CN. The Renin-Angiotensin System and Cardiovascular-Kidney-Metabolic Syndrome: Focus on Early-Life Programming.. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024. 25(6). 3298.. doi:10.3390/ijms25063298

Reference
Tain YL, Hsu CN. Amino Acids during Pregnancy and Offspring Cardiovascular-Kidney-Metabolic Health. Nutrients. 2024;16(9):1263. doi:10.3390/nu16091263

Reference
Varillas-Delgado D. Association of Genetic Profile with Muscle Mass Gain and Muscle Injury Prevention in Professional Football Players after Creatine Supplementation. Nutrients. 2024;16(15):2511. doi:10.3390/nu16152511

Reference
Tain YL, Hsu CN. Maternal Polyphenols and Offspring Cardiovascular-Kidney-Metabolic Health.. Nutrients. 2024. 16(18). 3168.. doi:10.3390/nu16183168

Reference
Ruiz-García A, Serrano-Cumplido A, Escobar-Cervantes C,. Prevalence Rates of Abdominal Obesity, High Waist-to-Height Ratio and Excess Adiposity, and Their Associated Cardio-Kidney-Metabolic Factors: SIMETAP-AO Study.. Nutrients. 2024. 16(22). 3948.. doi:10.3390/nu16223948

Reference
Carvalho LRRA, Tydén M, Shimari M, Zhuge Z, Schiffer TA. Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in Mice.. Nutrients. 2024. 16(23). 4105.. doi:10.3390/nu16234105

Reference
Li J, Lei L, Wang W, Ding W, Yu Y, Pu B, et al. Social Risk Profile and Cardiovascular-Kidney-Metabolic Syndrome in US Adults. Journal of the American Heart Association. 2024;13(16):e034996. doi:10.1161/JAHA.124.034996

Reference
Kong YW, Morrison D, Lu JC, Lee MH, Jenkins AJ. Continuous ketone monitoring: Exciting implications for clinical practice. DIABETES OBESITY and METABOLISM. 2024;26. doi:10.1111/dom.15921

Reference
Massy ZA, Drueke TB. eCollection 2024 Sep. Combination of Cardiovascular, Kidney, and Metabolic Diseases in a Syndrome Named Cardiovascular-Kidney-Metabolic, With New Risk Prediction Equations.. Kidney International Reports. 2024. 9(9). 2608-2618.. doi:10.1016/j.ekir.2024.05.033

Reference
Trimarco V, Izzo R, Pacella D, Virginia Manzi M, Trama U, Lembo. Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: A propensity score-matched study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024;218:111926. doi:10.1016/j.diabres.2024.111926

Reference
Vlaha DR, Zuza AV, Chen L, Harlaux M. Hot Cordilleran hinterland promoted lower crust mobility and decoupling of Laramide deformation.. Nature Communications. 2024. 15(1). 3750.. doi:10.1038/s41467-024-48182-8

Reference
Wong SPY, Oestreich T, Prince DK, Curtis JR. A Patient Decision Aid About Conservative Kidney Management in Advanced Kidney Disease: A Randomized Pilot Trial.. AMERICAN JOURNAL OF KIDNEY DISEASES. 2023. 82(2). 179-188.. doi:10.1053/j.ajkd.2022.12.007

Reference
Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.. Circulation. 2023. 148(20). 1636-1664.. doi:10.1161/CIR.0000000000001186

Reference
Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, et al. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.. Circulation. 2023. 148(24). 1982-2004.. doi:10.1161/CIR.0000000000001191

Reference
Chang KT, Jezek J, Campbell AN, Stieg DC, Kiss ZA, Kemper K,. Aberrant cyclin C nuclear release induces mitochondrial fragmentation and dysfunction in MED13L syndrome fibroblasts.. iScience. 2022. 25(2). 103823.. doi:10.1016/j.isci.2022.103823

Reference
Sun J, Liu PF, Liu JN, Lu C, Tong LT, Wang YQ, et al. Combined metabolomics and proteomics to reveal beneficial mechanisms of Dendrobium fimbriatum against gastric mucosal injury. Frontiers in Pharmacology. 2022;13:948987. doi:10.3389/fphar.2022.948987

Reference
Iyasere O, Brown EA, Johansson L, Davenport A, Farrington K,. 2019 Apr. Quality of life with conservative care compared with assisted peritoneal dialysis and haemodialysis.. Clinical Kidney Journal. 2018. 12(2). 262-268.. doi:10.1093/ckj/sfy059

Reference
Kristjansson RP, Oddsson A, Helgason H, Sveinbjornsson G. Common and rare variants associating with serum levels of creatine kinase and lactate dehydrogenase. Nature Communications. 2016;7:10572. doi:10.1038/ncomms10572

Reference
Kaizu Y, Ohkawa S, Odamaki M, Ikegaya N, Hibi I, Miyaji K, et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients.. AMERICAN JOURNAL OF KIDNEY DISEASES. 2003. 42(2). 295-302.. doi:10.1016/s0272-6386(03

Reference
Clark WR, Mueller BA, Kraus MA, Macias WL. Quantification of creatinine kinetic parameters in patients with acute renal failure. KIDNEY INTERNATIONAL. 1998;54(2):554-60. doi:10.1046/j.1523-1755.1998.00016.x

Reference
Canaud B, Leblanc M, Garred LJ, Bosc JY, Argilés A, Mion C. Protein catabolic rate over lean body mass ratio: a more rational approach to normalize the protein catabolic rate in dialysis patients. AMERICAN JOURNAL OF KIDNEY DISEASES. 1997;30(5):672-9. doi:10.1016/s0272-6386(97